AU2017315238A1 - Immunogenic composition - Google Patents

Immunogenic composition Download PDF

Info

Publication number
AU2017315238A1
AU2017315238A1 AU2017315238A AU2017315238A AU2017315238A1 AU 2017315238 A1 AU2017315238 A1 AU 2017315238A1 AU 2017315238 A AU2017315238 A AU 2017315238A AU 2017315238 A AU2017315238 A AU 2017315238A AU 2017315238 A1 AU2017315238 A1 AU 2017315238A1
Authority
AU
Australia
Prior art keywords
amino acid
influenza
composition
region
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017315238A
Other languages
English (en)
Inventor
Sunetra GUPTA
Craig Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Publication of AU2017315238A1 publication Critical patent/AU2017315238A1/en
Priority to AU2024227680A priority Critical patent/AU2024227680A1/en
Priority to AU2026200025A priority patent/AU2026200025A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/108—Orthomyxoviridae (F), e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2017315238A 2016-08-25 2017-08-25 Immunogenic composition Abandoned AU2017315238A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2024227680A AU2024227680A1 (en) 2016-08-25 2024-10-28 Immunogenic composition
AU2026200025A AU2026200025A1 (en) 2016-08-25 2026-01-05 Immunogenic composition

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1614485.9A GB201614485D0 (en) 2016-08-25 2016-08-25 Immunogenic composition
GB1614485.9 2016-08-25
PCT/GB2017/052510 WO2018037246A1 (en) 2016-08-25 2017-08-25 Immunogenic composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2024227680A Division AU2024227680A1 (en) 2016-08-25 2024-10-28 Immunogenic composition

Publications (1)

Publication Number Publication Date
AU2017315238A1 true AU2017315238A1 (en) 2019-02-21

Family

ID=57119951

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2017315238A Abandoned AU2017315238A1 (en) 2016-08-25 2017-08-25 Immunogenic composition
AU2024227680A Pending AU2024227680A1 (en) 2016-08-25 2024-10-28 Immunogenic composition
AU2026200025A Pending AU2026200025A1 (en) 2016-08-25 2026-01-05 Immunogenic composition

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2024227680A Pending AU2024227680A1 (en) 2016-08-25 2024-10-28 Immunogenic composition
AU2026200025A Pending AU2026200025A1 (en) 2016-08-25 2026-01-05 Immunogenic composition

Country Status (8)

Country Link
US (2) US11123422B2 (https=)
EP (1) EP3504235A1 (https=)
JP (2) JP7203015B2 (https=)
CN (1) CN109923125B (https=)
AU (3) AU2017315238A1 (https=)
CA (1) CA3034328A1 (https=)
GB (1) GB201614485D0 (https=)
WO (1) WO2018037246A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201614485D0 (en) * 2016-08-25 2016-10-12 Univ Oxford Innovation Ltd Immunogenic composition
WO2020061443A2 (en) * 2018-09-21 2020-03-26 Board Of Regents Of The University Of Nebraska Methods of making and using universal centralized influenza vaccine genes
GB2578163A (en) * 2018-10-19 2020-04-22 Univ Pretoria Plant produced avian influenza antigens and their uses in diagnostic assays and devices
GB202204478D0 (en) * 2022-03-29 2022-05-11 Univ Oxford Innovation Ltd Immunogenic compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
CA2035576A1 (en) 1990-02-07 1991-08-08 Alexander R. Neurath Conformational epitopes of human immunodeficiency virus envelope glycoprotein gp120 hiv-1
AU727602B2 (en) 1995-09-01 2000-12-14 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
AU2003228267A1 (en) * 2002-03-05 2003-09-22 Board Of Regents, The University Of Texas System Methods of enhancing immune induction involving mda-7
AU2006236910B2 (en) * 2005-04-11 2012-06-07 Purdue Research Foundation Vaccine against pandemic strains of influenza viruses
WO2007134327A2 (en) * 2006-05-15 2007-11-22 Sea Lane Biotechnologies, Llc. Neutralizing antibodies to influenza viruses
CN104140958A (zh) * 2006-08-09 2014-11-12 米迪缪尼有限公司 流感血凝素和神经氨酸酶变体
NZ590351A (en) 2008-07-18 2012-11-30 Medicago Inc HA1 domain totally or partially free of N-linked glycosylation operatively linked to a regulatory region
WO2011126370A1 (en) 2010-04-09 2011-10-13 Universiteit Utrecht Holding B.V. Recombinant multimeric influenza proteins
CA2807664A1 (en) * 2010-08-12 2012-02-16 Theraclone Sciences, Inc. Anti-hemagglutinin antibody compositions and methods of use thereof
US8883171B2 (en) 2010-09-14 2014-11-11 University of Pittsburgh—of the Commonwealth System of Higher Education Computationally optimized broadly reactive antigens for influenza
WO2012089231A1 (en) 2010-12-30 2012-07-05 Okairòs Ag Paramyxovirus vaccines
CN104582714A (zh) * 2012-05-23 2015-04-29 斯坦福大学托管董事会 流感疫苗构建体
US8932598B2 (en) * 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use
ES2803508T3 (es) 2013-03-28 2021-01-27 Medicago Inc Producción de partículas similares al virus de la gripe en plantas
GB201614485D0 (en) * 2016-08-25 2016-10-12 Univ Oxford Innovation Ltd Immunogenic composition

Also Published As

Publication number Publication date
WO2018037246A4 (en) 2018-04-19
US20190201521A1 (en) 2019-07-04
AU2026200025A1 (en) 2026-01-22
JP2019534242A (ja) 2019-11-28
JP2023052092A (ja) 2023-04-11
US20220054625A1 (en) 2022-02-24
GB201614485D0 (en) 2016-10-12
CN109923125A (zh) 2019-06-21
WO2018037246A1 (en) 2018-03-01
US11123422B2 (en) 2021-09-21
EP3504235A1 (en) 2019-07-03
AU2024227680A1 (en) 2024-11-21
JP7762643B2 (ja) 2025-10-30
US12390518B2 (en) 2025-08-19
CA3034328A1 (en) 2018-03-01
JP7203015B2 (ja) 2023-01-12
CN109923125B (zh) 2024-05-31

Similar Documents

Publication Publication Date Title
US12390518B2 (en) Immunogenic composition
JP7655849B2 (ja) ヘマグルチニン（ｈａ）タンパク質内の非ドミナントエピトープに対する免疫応答を誘起するためのベクター
US20230165952A1 (en) Betacoronavirus prophylaxis and therapy
US10729758B2 (en) Broadly reactive mosaic peptide for influenza vaccine
CN105452270B (zh) 流行性感冒病毒疫苗及其用途
CN111526886A (zh) 多基因流感疫苗
JP2022538673A (ja) アフリカ豚熱ワクチン
US20140255343A1 (en) Dna vaccine, method of inducing the immune response, method of immunisation, antibodies specifically recognising the h5 haemagglutinin of an influenza virus and use of the dna vaccine
US9963490B2 (en) Influenza nucleoprotein vaccines
JP2023522154A (ja) インフルエンザワクチン
CN102612559B (zh) 源自流感m2的修饰的肽疫苗
EP3713600B1 (en) Synthetic hemagglutinin as universal vaccine against infection by type b influenza viruses (ibv)
US20260007734A1 (en) Immunogenic compositions for the prevention of influenza a
JP4797149B2 (ja) インフルエンザウイルスに対するベクターワクチン
WO2026074282A1 (en) Influenza vaccines
WO2024235368A1 (es) Composicion vacunal contra el virus de la peste porcina africana

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted